DURECT Corporation

NasdaqCM:DRRX Stock Report

Market Cap: US$28.9m

DURECT Management

Management criteria checks 3/4

DURECT's CEO is Jim Brown, appointed in Feb 1998, has a tenure of 26.17 years. total yearly compensation is $1.45M, comprised of 40.6% salary and 59.4% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth $223.94K. The average tenure of the management team and the board of directors is 6.3 years and 5 years respectively.

Key information

Jim Brown

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage40.6%
CEO tenure26.2yrs
CEO ownership0.8%
Management average tenure6.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Aug 08
Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Durect names ex-RBC Capital Markets executive as CFO

Jul 05

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

Mar 14
DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 10
DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Durect (DRRX) Investor Presentation - Slideshow

May 06

Durect EPS misses by $0.01, misses on revenue

May 04

DURECT prices ~$43M stock offering

Feb 04

DURECT surges after FDA approval for Posimir

Feb 02

Durect's DUR-928 fast track'd for alcoholic hepatitis in the U.S.

Dec 16

DURECT (DRRX) Investor Presentation - Slideshow

Oct 31

CEO Compensation Analysis

How has Jim Brown's remuneration changed compared to DURECT's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$586k

-US$28m

Sep 30 2023n/an/a

-US$37m

Jun 30 2023n/an/a

-US$36m

Mar 31 2023n/an/a

-US$36m

Dec 31 2022US$2mUS$575k

-US$35m

Sep 30 2022n/an/a

-US$32m

Jun 30 2022n/an/a

-US$39m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$1mUS$555k

-US$36m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$37m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$1mUS$539k

-US$14m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$3m

Mar 31 2020n/an/a

-US$24m

Dec 31 2019US$1mUS$531k

-US$21m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$24m

Mar 31 2019n/an/a

-US$24m

Dec 31 2018US$1mUS$531k

-US$25m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$962k

Mar 31 2018n/an/a

-US$4m

Dec 31 2017US$1mUS$531k

-US$4m

Compensation vs Market: Jim's total compensation ($USD1.45M) is above average for companies of similar size in the US market ($USD673.68K).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.

CEO

Jim Brown (66 yo)

26.2yrs

Tenure

US$1,445,784

Compensation

Dr. James E. Brown, also known as Jim, D.V.M., serves as Life Science Advisor since 2021 at K2X Technology & Life Science, Inc. He Co-founded DURECT Corporation in February 1998 and has been its President...

Leadership Team

NamePositionTenureCompensationOwnership
James Brown
Co-Founder26.2yrsUS$1.45m0.77%
$ 223.9k
Timothy Papp
CFO & Secretary1.8yrsUS$671.31k0%
$ 0
Norman Sussman
Chief Medical Officer3.4yrsUS$654.48k0.0029%
$ 838.2
Judy Joice
Senior Vice President of Operations & Corporate Quality Assurance10.1yrsUS$713.55k0%
$ 0
WeiQi Lin
Executive VP of Research & Development and Principal Scientistno datano datano data
Keith Lui
Senior Vice President of Business Development1.6yrsno datano data
Jian Li
Senior VP of Finance23yrsUS$452.77kno data
Su Yum
Executive Officer6.3yrsUS$430.63kno data

6.3yrs

Average Tenure

66yo

Average Age

Experienced Management: DRRX's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Brown
Co-Founder25.8yrsUS$1.45m0.77%
$ 223.9k
Gail Maderis
Independent Chairman of the Board3.3yrsUS$109.74k0.064%
$ 18.6k
Mohammad Azab
Independent Director3.3yrsUS$81.62k0.019%
$ 5.6k
Terrence Blaschke
Independent Director17.3yrsUS$83.12k0.010%
$ 2.9k
Peter Garcia
Independent Director2.3yrsUS$84.73k0.023%
$ 6.5k
Judith Robertson
Independent Director5yrsUS$83.12k0.11%
$ 33.2k
Gail Farfel
Director5yrsUS$70.62k0.032%
$ 9.3k

5.0yrs

Average Tenure

66yo

Average Age

Experienced Board: DRRX's board of directors are considered experienced (5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.